Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check13 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedVersion 92 was added to the history on 2026-09-25 with a Study Status update. An older entry dated 2026-08-28 was removed.SummaryDifference0.2%

- Check34 days agoChange DetectedA new Revision: v3.7.0 entry was added to the Record History, replacing the previous v3.6.6 entry. This records a page update in the study’s history.SummaryDifference0.0%

- Check55 days agoChange DetectedA new history entry dated 2026-08-28 with the Study Status was added, introducing revision v3.6.6; the older entry dated 2026-07-31 with revision v3.6.5 was removed.SummaryDifference0.2%

- Check62 days agoChange DetectedA References section has been added to the study record history, providing citations and sources for the study updates. This addition helps users locate supporting materials linked to prior submissions.SummaryDifference0.1%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.